{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:21:43Z","timestamp":1784089303773,"version":"3.55.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229772","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T18:41:01Z","timestamp":1583260861000},"page":"e0229772","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-199X","authenticated-orcid":true,"given":"Hironao","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-9993","authenticated-orcid":true,"given":"Hitoshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoki","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Kokubu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,3]]},"reference":[{"key":"pone.0229772.ref001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12072-019-09929-4","article-title":"The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting","volume":"13","author":"S Obi","year":"2019","journal-title":"Hepatol Int"},{"key":"pone.0229772.ref002","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/cam4.1909","article-title":"Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis","volume":"8","author":"A Hiraoka","year":"2019","journal-title":"Cancer Med"},{"key":"pone.0229772.ref003","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"M Kudo","year":"2018","journal-title":"Lancet"},{"key":"pone.0229772.ref004","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/jat.1716","article-title":"A review of the logistic role of L-carnitine in the management of radiation toxicity and radiotherapy side effects","volume":"31","author":"HA Khan","year":"2011","journal-title":"J Appl Toxicol"},{"key":"pone.0229772.ref005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MPH.0b013e3181b259a7","article-title":"Carnitine plasma levels and fatigue in children\/adolescents receiving cisplatin, ifosfamide, or doxorubicin","volume":"31","author":"MJ Hockenberry","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"pone.0229772.ref006","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/00016489.2015.1030769","article-title":"Carnitine is associated with fatigue following chemoradiotherapy for head and neck cancer","volume":"135","author":"K Endo","year":"2015","journal-title":"Acta Otolaryngol"},{"key":"pone.0229772.ref007","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.anl.2018.10.007","article-title":"Auris Effects of l-carnitine administration on health-related quality of life during cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma","volume":"46","author":"K Endo","year":"2019","journal-title":"Nasus Larynx"},{"key":"pone.0229772.ref008","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/1078-0432.CCR-10-1239","article-title":"Cisplatin-induced downregulation of OCTN2 affects carnitine wasting","volume":"16","author":"CS Lancaster","year":"2010","journal-title":"Clin Cancer Res"},{"key":"pone.0229772.ref009","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"SE Reuter","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"pone.0229772.ref010","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/mol.59.2.358","article-title":"Molecular and physiological evidence for multifunctionality of carnitine\/organic cation transporter OCTN2","volume":"59","author":"R Ohashi","year":"2001","journal-title":"Mol Pharmacol"},{"key":"pone.0229772.ref011","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jcp.22054","article-title":"Expression of OCTN2 and OCTN3 in the apical membrane of rat renal cortex and medulla","volume":"223","author":"MM Cano","year":"2010","journal-title":"J Cell Physiol"},{"key":"pone.0229772.ref012","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"273","author":"I Tamai","year":"1998","journal-title":"J Biol Chem"},{"key":"pone.0229772.ref013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bdd.1816","article-title":"Pharmacological and pathophysiological roles of carnitine\/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21)","volume":"34","author":"I Tamai","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"pone.0229772.ref014","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"S Hu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"pone.0229772.ref015","first-page":"778","article-title":"Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance","volume":"291","author":"R Ohashi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0229772.ref016","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1535-7163.MCT-11-0980","article-title":"Inhibition of OCTN2-mediated transport of carnitine by etoposide","volume":"11","author":"C Hu","year":"2012","journal-title":"Mol Cancer Therap"},{"key":"pone.0229772.ref017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0885-3924(02)00596-1","article-title":"Validation study of the Japanese version of the brief fatigue inventory","volume":"25","author":"T Okuyama","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"pone.0229772.ref018","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N","article-title":"The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory","volume":"85","author":"TR Mendoza","year":"1999","journal-title":"Cancer"},{"key":"pone.0229772.ref019","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/clinchem\/40.5.817","article-title":"Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase","volume":"40","author":"M Takahashi","year":"1994","journal-title":"Clin Chem"},{"key":"pone.0229772.ref020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"R Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"pone.0229772.ref021","first-page":"303","article-title":"Transport and functions of carnitine in muscles","volume":"28","author":"N Siliprandi","year":"1990","journal-title":"J Clin Chem Clin Biochem"},{"key":"pone.0229772.ref022","unstructured":"Japan Pediatric Society: http:\/\/www.jpeds.or.jp\/modules\/guidelines\/index.php?content_id=2 (accessed November 21, 2019)."},{"key":"pone.0229772.ref023","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and acetyl-L-carnitine roles and neuroprotection in developing brain","volume":"42","author":"GC Ferreira","year":"2017","journal-title":"Neurochem Res"},{"key":"pone.0229772.ref024","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mus.880160205","article-title":"Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy","volume":"16","author":"Y Campos","year":"1993","journal-title":"Muscle Nerve"},{"key":"pone.0229772.ref025","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1007\/BF02138779","article-title":"Carnitine esters in metabolic disease","volume":"153","author":"H B\u00f6hles","year":"1994","journal-title":"Eur J Pediatr"},{"key":"pone.0229772.ref026","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.21873\/anticanres.13710","article-title":"Impact of relative dose intensity of early-phase lenvatinib treatment on therapeutic response in hepatocellular carcinoma","volume":"39","author":"A Takahashi","year":"2019","journal-title":"Anticancer Res"},{"key":"pone.0229772.ref027","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2011.40.2180","article-title":"L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial","volume":"30","author":"RA Cruciani","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"pone.0229772.ref028","doi-asserted-by":"crossref","first-page":"E1224","DOI":"10.3390\/nu9111224","article-title":"Efficacy and effectiveness of carnitine supplementation for cancer-related fatigue: A systematic literature review and meta-analysis","volume":"9","author":"W Marx","year":"2017","journal-title":"Nutrients"},{"key":"pone.0229772.ref029","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2018-01836","article-title":"Primary adrenal insufficiency during lenvatinib or vandetanib and improvement of fatigue after cortisone acetate therapy","volume":"104","author":"C Colombo","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T14:37:54Z","timestamp":1722523074000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229772"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Kanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,3]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229772","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,3]]}}}